185 related articles for article (PubMed ID: 6741873)
21. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
Wieczorek R; Buck D; Bindl J; Knowles DM
Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
[TBL] [Abstract][Full Text] [Related]
22. The Lewis X antigen. A new paraffin section marker for Reed-Sternberg cells.
Ree HJ; Teplitz C; Khan A
Cancer; 1991 Mar; 67(5):1338-46. PubMed ID: 1703918
[TBL] [Abstract][Full Text] [Related]
23. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
[TBL] [Abstract][Full Text] [Related]
24. Leu M-1 antigen: comparative expression in Hodgkin's disease and T cell lymphoma.
Strauchen JA; Breakstone B
Hematol Oncol; 1987; 5(2):107-14. PubMed ID: 2885252
[TBL] [Abstract][Full Text] [Related]
25. Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases.
Sheibani K; Battifora H; Burke JS; Rappaport H
Am J Surg Pathol; 1986 Apr; 10(4):227-36. PubMed ID: 3085523
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells?
Hsu SM; Hsu PL
Am J Pathol; 1989 Jan; 134(1):203-12. PubMed ID: 2492402
[TBL] [Abstract][Full Text] [Related]
27. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
Frierson HF; Innes DJ
Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
[TBL] [Abstract][Full Text] [Related]
29. Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution.
Chittal SM; Alard C; Rossi JF; al Saati T; Le Tourneau A; Diebold J; Delsol G
Am J Surg Pathol; 1990 Nov; 14(11):1024-35. PubMed ID: 2240355
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.
Dorreen MS; Habeshaw JA; Stansfeld AG; Wrigley PF; Lister TA
Br J Cancer; 1984 Apr; 49(4):465-76. PubMed ID: 6370286
[TBL] [Abstract][Full Text] [Related]
31. Ki-M6 immunostaining in routinely processed sections of reactive and neoplastic human lymphoid tissue.
Gloghini A; Volpe R; Carbone A
Am J Clin Pathol; 1990 Dec; 94(6):734-41. PubMed ID: 2244592
[TBL] [Abstract][Full Text] [Related]
32. Immunologic marker analysis of normal and malignant histiocytes. A comparative study of monoclonal antibodies for diagnostic purposes.
Roholl PJ; Kleyne J; Prins ME; Hooijkaas H; Vroom TM; Van Unnik JA
Am J Clin Pathol; 1988 Feb; 89(2):187-94. PubMed ID: 3341278
[TBL] [Abstract][Full Text] [Related]
33. Lectin receptors as markers of lymphoid cells. II. Reed-Sternberg cells share lectin-binding properties of monocyte macrophages.
Strauchen JA
Am J Pathol; 1984 Sep; 116(3):370-6. PubMed ID: 6206728
[TBL] [Abstract][Full Text] [Related]
34. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous expression of activated lymphoid cell-associated and granulocytic cell-associated antigens on Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
Abe M; Wachi E; Wakasa H
Pathol Res Pract; 1988 Aug; 183(4):418-24. PubMed ID: 3186542
[TBL] [Abstract][Full Text] [Related]
36. Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease.
Ree HJ; Kadin ME
Cancer; 1985 Jul; 56(2):333-8. PubMed ID: 2408733
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease.
Dorfman RF; Gatter KC; Pulford KA; Mason DY
Am J Pathol; 1986 Jun; 123(3):508-19. PubMed ID: 3717303
[TBL] [Abstract][Full Text] [Related]
38. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
Kadin ME; Muramoto L; Said J
Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
[TBL] [Abstract][Full Text] [Related]
40. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
